BRITTANY SCHUPBACH: Open Payments
NPI 1063843944 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,417 in 194 payments from 21 companies in 2025. Trend: 2023 $2,391 · 2024 $3,099 · 2025 $3,417
Food & beverage: $3,317Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $397 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $321 |
| ABBVIE INC. | 18 | $297 |
| Incyte Corporation | 17 | $264 |
| Janssen Biotech, Inc. | 10 | $239 |
| GENZYME CORPORATION | 16 | $226 |
| MAYNE PHARMA COMMERCIAL LLC | 25 | $224 |
| Arcutis Biotherapeutics, Inc. | 14 | $208 |
| Lilly USA, LLC | 5 | $202 |
| UCB, Inc. | 9 | $192 |
Products named: DUPIXENT, OPZELURA, TREMFYA, Zoryve, SKYRIZI, Bimzelx, ILUMYA, CIBINQO.
Industry payments across TX — which companies pay providers there.
